Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Liver transplants offer new hope for bile duct cancer patients

NCT ID NCT06140134

First seen Mar 25, 2026 · Last updated May 26, 2026 · Updated 11 times

Summary

This study is for people with a type of bile duct cancer that cannot be removed by surgery and has not spread. Participants will receive chemotherapy first, and if the cancer stays stable or shrinks for at least 6 months, they may get a liver transplant. The goal is to see if this approach helps people live longer than chemotherapy alone. About 30 adults will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rutgers New Jersey Medical School

    RECRUITING

    Newark, New Jersey, 07103, United States

    Contact Email: •••••@•••••

  • University Hospital

    RECRUITING

    Newark, New Jersey, 07103, United States

    Contact

    Contact

    Contact

    Contact

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.